Two experts see major challenges facing the adoption of new obesity drugs.
However, she considers data supporting the use of obesity drugs for other conditions including Alzheimer's and alcohol addiction as underdeveloped.
Novo Nordisk halted FLOW on Tuesday.
As of Friday's close, Novo Nordisk is up 9.82% since its announcement.
"Right now, we are seeing active employers, entire states that are declining to cover on the weight loss indication," Patel said.
Persons:
Kavita Patel, CNBC's, I've, Eli Lilly, Patel, Obama
Organizations:
NBC, Novo Nordisk, Nordisk, White, Health
Locations:
Novo